SRPT - Sarepta Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SRPT is currently covered by 22 analysts with an average price target of $167.47. This is a potential upside of $44.01 (35.65%) from yesterday's end of day stock price of $123.46.

Sarepta Therapeutics's activity chart (see below) currently has 549 price targets and 509 ratings on display. The stock rating distribution of SRPT is 20.69% HOLD and 79.31% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 56.67% with an average time for these price targets to be met of 234.73 days.

Highest price target for SRPT is $224, Lowest price target is $103, average price target is $167.47.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 20-May-2024. First documented stock forecast 20-Mar-2013.

Currently out of the existing stock ratings of SRPT, 24 are a HOLD (20.69%), 92 are a BUY (79.31%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

166

$42.54 (34.46%)

166

6 days ago

8/21 (38.1%)

$35.17 (26.88%)

248

Buy

179

$55.54 (44.99%)

145

9 days ago

1/6 (16.67%)

$47.62 (36.25%)

58

Hold

180

$56.54 (45.80%)

180

12 days ago

10/13 (76.92%)

$47.34 (35.69%)

252

Buy

175

$51.54 (41.75%)

177

23 days ago

9/16 (56.25%)

$41.34 (30.93%)

125

Hold

128

$4.54 (3.68%)

128

24 days ago

4/9 (44.44%)

$-2.63 (-2.01%)

51

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SRPT (Sarepta Therapeutics) average time for price targets to be met?

On average it took 234.73 days on average for the stock forecasts to be realized with a an average price target met ratio 56.67

Which analyst has the current highest performing score on SRPT (Sarepta Therapeutics) with a proven track record?

SIMOS SIMEONIDIS

Which analyst has the most public recommendations on SRPT (Sarepta Therapeutics)?

Simos Simeonidis has 4 price targets and 5 ratings on SRPT

Which analyst is the currently most bullish on SRPT (Sarepta Therapeutics)?

Christopher Marai with highest potential upside - $106.54

Which analyst is the currently most reserved on SRPT (Sarepta Therapeutics)?

Robyn Karnauskas with lowest potential downside - -$99.46

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?